Quipt Home Medical Acquisition Clears HSR Antitrust Hurdle
QIPT has more than doubled off its 52-week low of $1.35.
Summary
Quipt Home Medical Corp. announced that the HSR Act waiting period for its all-cash acquisition by 1567208 B.C. Ltd. has expired, satisfying a key closing condition for the $3.65 per share deal.
Key Events · M&A and Partnerships · QIPT
-
HSR Waiting Period Expired
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired on January 22, 2026, for the proposed acquisition.
-
Key Acquisition Condition Met
The HSR expiration satisfies one of the conditions required for the closing of the previously announced all-cash acquisition at $3.65 per share.
-
Progress Towards Deal Closure
This development follows previous disclosures regarding the acquisition and the scheduling of a special shareholder meeting for approval, moving the deal closer to completion.
Analysis · QIPT · Industrial Applications And Services
This 8-K filing provides a significant update on the previously announced acquisition of Quipt Home Medical Corp. for $3.65 per share. The expiration of the Hart-Scott-Rodino waiting period removes a major regulatory hurdle, increasing the probability of the deal closing. This development follows earlier filings in January regarding the scheduling of a special shareholder meeting to vote on the transaction. While shareholder approval and other customary conditions remain, this marks a positive step towards the completion of the acquisition.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QIPT was trading at $3.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $157.6M. The 52-week trading range was $1.35 to $3.61. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.